Profound Medical Corp. (PROF)

Profound Medical Cash Flow Statement

Financials in millions CAD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-33.38	-16.58	-30.52	-24.42	-19.71
Depreciation & Amortization	1.15	1.6	1.88	1.54	1.51
Share-Based Compensation	3.42	4.24	7.21	3.02	1.27
Other Operating Activities	6.52	-15.06	-0.92	-0.71	1.89
Operating Cash Flow	-22.3	-25.8	-22.36	-20.57	-15.05
Capital Expenditures	0	0	-0.03	0	0
Other Investing Activities	-	-	-0.56	-0.35	-0.19
Investing Cash Flow	0	0	-0.59	-0.35	-0.19
Share Issuance / Repurchase	2.67	0.26	6.43	103.68	8.71
Debt Issued / Paid	-1.2	6.77	-0.39	-9.61	-1.25
Other Financing Activities	-	-	-0.1	-6.64	-0.87
Financing Cash Flow	1.46	7.03	5.95	87.43	6.6
Net Cash Flow	-20.83	-18.77	-17.01	66.51	-8.64
Free Cash Flow	-22.3	-25.8	-22.39	-20.57	-15.05
Free Cash Flow Margin	-309.72%	-386.17%	-325.80%	-281.68%	-360.57%
Free Cash Flow Per Share	-1.04	-1.24	-1.08	-1.05	-1.27

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).